
Atea Pharmaceuticals (AVIR) Earnings Dates & Reports
Atea Pharmaceuticals (AVIR) Most Recent Earnings
Report DateAug 7, 2025
Period EndingQ2 2025
Est. EPS-$0.43
Actual EPS-$0.44
EarningsMiss
Atea Pharmaceuticals (AVIR) Earnings
View the latest Atea Pharmaceuticals (AVIR) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Atea Pharmaceuticals (AVIR)
Order type
Buy in
Order amount
Est. shares
0 shares
Atea Pharmaceuticals (AVIR) Earnings per Share (EPS) History
Signup for full accessBrowse free
Atea Pharmaceuticals (AVIR) Latest Earnings
The value each AVIR share was expected to gain vs. the value each share gained.
Atea Pharmaceuticals (AVIR) reported its most recent earnings on Aug 7, 2025 for Q2 2025, posting earnings per share (EPS) of -$0.44. This exceeded analysts' expectations of -$0.43 by 2.33%, marking a Miss.
For comparison, Atea Pharmaceuticals reported EPS of -$0.48 in the same quarter last year.
The company is expected to announce its next earnings report on 11/06/2025, with analysts projecting an EPS of -$0.43.
Atea Pharmaceuticals (AVIR) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q3 2025Nov 6, 2025 | -$0.43 | Next earnings call Nov. 6, 2025 | ||
Q2 2025Aug 7, 2025 | -$0.43 | -$0.44 | +2.33% | |
Q1 2025May 12, 2025 | -$0.41 | -$0.40 | -2.44% | |
Q4 2024Mar 6, 2025 | -$0.29 | -$0.40 | +37.93% | |
Q3 2024Nov 7, 2024 | -$0.49 | -$0.37 | -24.49% | |
Atea Pharmaceuticals (AVIR) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Atea Pharmaceuticals’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Aug 7, 2025 | — | — | — |
May 12, 2025 | — | — | — |
Mar 6, 2025 | — | — | — |
Nov 7, 2024 | — | — | — |
Atea Pharmaceuticals (AVIR) Earnings FAQs
Atea Pharmaceuticals (AVIR) last reported earnings on Aug 7, 2025 for Q2 2025, posting an EPS of -$0.44, which Miss the estimate of -$0.43 by 2.33%.
For Q2 2025, Atea Pharmaceuticals (AVIR) reported an EPS of -$0.44, missing analysts' estimate of -$0.43 by 2.33%.
For Q2 2025, Atea Pharmaceuticals (AVIR) Miss expectations with an actual EPS of -$0.44 vs. an estimated EPS of -$0.43.
Following the last earnings report on Aug 7, 2025, Atea Pharmaceuticals (AVIR)'s stock price moved — from — to —.
The next Atea Pharmaceuticals (AVIR) earnings call is scheduled for Nov. 6, 2025, where executives will discuss financial results and outlook.